{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:11:35Z","timestamp":1791216695934,"version":"4.1.0"},"reference-count":47,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,2,16]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pulmonary arterial hypertension (PAH) is a progressive disease characterized by lung endothelial dysfunction and vascular remodeling. Recently, bone marrow progenitor cells have been localized to PAH lungs, raising the question of their role in disease progression. Independently, serotonin (5-HT) and its receptors have been identified as contributors to the PAH pathogenesis. We hypothesized that 1 of these receptors, 5-HT2B, is involved in bone marrow stem cell mobilization that participates in the development of PAH and pulmonary vascular remodeling. A first study revealed expression of 5-HT2B receptors by circulating c-kit+ precursor cells, whereas mice lacking 5-HT2B receptors showed alterations in platelets and monocyte-macrophage numbers, and in myeloid lineages of bone marrow. Strikingly, mice with restricted expression of 5-HT2B receptors in bone marrow cells developed hypoxia or monocrotaline-induced increase in pulmonary pressure and vascular remodeling, whereas restricted elimination of 5-HT2B receptors on bone marrow cells confers a complete resistance. Moreover, ex vivo culture of human CD34+ or mice c-kit+ progenitor cells in the presence of a 5-HT2B receptor antagonist resulted in altered myeloid differentiation potential. Thus, we demonstrate that activation of 5-HT2B receptors on bone marrow lineage progenitors is critical for the development of PAH.<\/jats:p>","DOI":"10.1182\/blood-2011-06-358374","type":"journal-article","created":{"date-parts":[[2011,12,21]],"date-time":"2011-12-21T06:56:47Z","timestamp":1324450607000},"page":"1772-1780","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":94,"title":["Serotonin 5-HT2B receptors are required for bone-marrow contribution to pulmonary arterial hypertension"],"prefix":"10.1182","volume":"119","author":[{"given":"Jean-Marie","family":"Launay","sequence":"first","affiliation":[{"name":"Inserm U942, Assistance Publique\u2013H\u00f4pitaux de Paris (AP-HP), H\u00f4pital Lariboisi\u00e8re, Service de Biochimie, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Herv\u00e9","sequence":"additional","affiliation":[{"name":"Centre Chirurgical Marie Lannelongue, Le Plessis, Robinson, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Callebert","sequence":"additional","affiliation":[{"name":"Inserm U942, Assistance Publique\u2013H\u00f4pitaux de Paris (AP-HP), H\u00f4pital Lariboisi\u00e8re, Service de Biochimie, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad","family":"Mallat","sequence":"additional","affiliation":[{"name":"Inserm U970, Paris Centre de Recherche Cardiovasculaire, Hopital Europ\u00e9en Georges Pompidou, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Collet","sequence":"additional","affiliation":[{"name":"Inserm U942, Assistance Publique\u2013H\u00f4pitaux de Paris (AP-HP), H\u00f4pital Lariboisi\u00e8re, Service de Biochimie, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Doly","sequence":"additional","affiliation":[{"name":"Inserm Unite Mixt\u00e9 de Recherche (UMR)\u2013S 839, Universit\u00e9 Pierre et Marie Curie and Institut du Fer \u00e0 Moulin, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnauld","family":"Belmer","sequence":"additional","affiliation":[{"name":"Inserm Unite Mixt\u00e9 de Recherche (UMR)\u2013S 839, Universit\u00e9 Pierre et Marie Curie and Institut du Fer \u00e0 Moulin, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvina L.","family":"Diaz","sequence":"additional","affiliation":[{"name":"Inserm Unite Mixt\u00e9 de Recherche (UMR)\u2013S 839, Universit\u00e9 Pierre et Marie Curie and Institut du Fer \u00e0 Moulin, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Hatia","sequence":"additional","affiliation":[{"name":"Centre National de la Recherche Scientifique UMR 8147, Universit\u00e9 Paris Descartes, Paris, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francine","family":"C\u00f4t\u00e9","sequence":"additional","affiliation":[{"name":"Centre National de la Recherche Scientifique UMR 8147, Universit\u00e9 Paris Descartes, Paris, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Humbert","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Sud 11, Inserm U999, Service de Pneumologie et R\u00e9animation Respiratoire, H\u00f4pital Antoine B\u00e9cl\u00e8re, AP-HP, Clamart, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Maroteaux","sequence":"additional","affiliation":[{"name":"Inserm Unite Mixt\u00e9 de Recherche (UMR)\u2013S 839, Universit\u00e9 Pierre et Marie Curie and Institut du Fer \u00e0 Moulin, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"18","key":"2019111809433455900_B1","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1161\/CIRCULATIONAHA.108.847707","article-title":"Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies.","volume":"121","author":"Archer","year":"2010","journal-title":"Circulation"},{"issue":"7","key":"2019111809433455900_B2","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1161\/01.RES.0000243584.45145.3f","article-title":"Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms.","volume":"99","author":"Stenmark","year":"2006","journal-title":"Circ Res"},{"issue":"6","key":"2019111809433455900_B3","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1161\/01.RES.0000243210.79654.fd","article-title":"Stem cell factor deficiency is vasculoprotective: unraveling a new therapeutic potential of imatinib mesylate.","volume":"99","author":"Wang","year":"2006","journal-title":"Circ Res"},{"issue":"3","key":"2019111809433455900_B4","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2353\/ajpath.2008.070705","article-title":"Circulating angiogenic precursors in idiopathic pulmonary arterial hypertension.","volume":"172","author":"Asosingh","year":"2008","journal-title":"Am J Pathol"},{"issue":"4","key":"2019111809433455900_B5","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1634\/stemcells.2007-0562","article-title":"Sustained endothelial progenitor cell dysfunction after chronic hypoxia-induced pulmonary hypertension.","volume":"26","author":"Marsboom","year":"2008","journal-title":"Stem Cells"},{"issue":"2","key":"2019111809433455900_B6","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2353\/ajpath.2006.050599","article-title":"Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte\/macrophage lineage.","volume":"168","author":"Frid","year":"2006","journal-title":"Am J Pathol"},{"issue":"5","key":"2019111809433455900_B7","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1378\/chest.127.5.1793","article-title":"Bone marrow-derived cells contribute to pulmonary vascular remodeling in hypoxia-induced pulmonary hypertension.","volume":"127","author":"Hayashida","year":"2005","journal-title":"Chest"},{"issue":"4","key":"2019111809433455900_B8","doi-asserted-by":"crossref","first-page":"L668","DOI":"10.1152\/ajplung.00108.2003","article-title":"Hypoxia-induced pulmonary artery adventitial remodeling and neovascularization: contribution of progenitor cells.","volume":"286","author":"Davie","year":"2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"2019111809433455900_B9","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.tcm.2010.03.003","article-title":"Endothelial progenitor cells in pulmonary arterial hypertension.","volume":"20","author":"Diller","year":"2010","journal-title":"Trends Cardiovasc Med"},{"issue":"13","key":"2019111809433455900_B10","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1182\/blood-2011-02-332643","article-title":"Bad blood, bad endothelium: ill fate?","volume":"117","author":"Yoder","year":"2011","journal-title":"Blood"},{"issue":"3","key":"2019111809433455900_B11","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000091638","article-title":"Pulmonary arterial hypertension after childhood cancer therapy and bone marrow transplantation.","volume":"105","author":"Limsuwan","year":"2006","journal-title":"Cardiology"},{"issue":"13","key":"2019111809433455900_B12","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1182\/blood-2010-09-306357","article-title":"Hypoxia-inducible factors in human pulmonary arterial hypertension: a link to the intrinsic myeloid abnormalities.","volume":"117","author":"Farha","year":"2011","journal-title":"Blood"},{"issue":"1","key":"2019111809433455900_B13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1365-2141.2003.04739.x","article-title":"Severe pulmonary hypertension: a frequent complication of stem cell transplantation for malignant infantile osteopetrosis.","volume":"124","author":"Steward","year":"2004","journal-title":"Br J Haematol"},{"issue":"1","key":"2019111809433455900_B14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.yjmcc.2007.09.006","article-title":"Pathogenic mechanisms of pulmonary arterial hypertension.","volume":"44","author":"Chan","year":"2008","journal-title":"J Mol Cell Cardiol"},{"issue":"2","key":"2019111809433455900_B15","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1183\/09031936.00160407","article-title":"Fenfluramine: riddle or Rosetta stone?","volume":"31","author":"Weir","year":"2008","journal-title":"Eur Respir J"},{"issue":"10","key":"2019111809433455900_B16","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/nm764","article-title":"Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension.","volume":"8","author":"Launay","year":"2002","journal-title":"Nat Med"},{"issue":"5","key":"2019111809433455900_B17","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1183\/09031936.00126010","article-title":"Terguride ameliorates monocrotaline-induced pulmonary hypertension in rats.","volume":"37","author":"Dumitrascu","year":"2011","journal-title":"Eur Respir J"},{"issue":"1","key":"2019111809433455900_B18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejphar.2011.08.015","article-title":"C-122, a novel antagonist of serotonin receptor 5-HT(2B), prevents monocrotaline-induced pulmonary arterial hypertension in rats.","volume":"670","author":"Zopf","year":"2011","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"2019111809433455900_B19","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1124\/jpet.109.165001","article-title":"PRX-08066, a novel 5-hydroxytryptamine receptor 2B antagonist, reduces monocrotaline-induced pulmonary arterial hypertension and right ventricular hypertrophy in rats.","volume":"334","author":"Porvasnik","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"issue":"7","key":"2019111809433455900_B20","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1634\/stemcells.2007-0048","article-title":"Promoting effects of serotonin on hematopoiesis: ex vivo expansion of cord blood CD34+ stem\/progenitor cells, proliferation of bone marrow stromal cells, and antiapoptosis.","volume":"25","author":"Yang","year":"2007","journal-title":"Stem Cells"},{"issue":"16","key":"2019111809433455900_B21","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra035488","article-title":"Pulmonary arterial hypertension.","volume":"351","author":"Farber","year":"2004","journal-title":"N Engl J Med"},{"key":"2019111809433455900_B22","doi-asserted-by":"crossref","first-page":"9508","DOI":"10.1073\/pnas.97.17.9508","article-title":"Serotonin 2B receptor is required for heart development.","volume":"97","author":"Nebigil","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"2019111809433455900_B23","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1161\/01.ATV.0000231527.22762.71","article-title":"Role of bone marrow-derived CC-chemokine receptor 5 in the development of atherosclerosis of low-density lipoprotein receptor knockout mice.","volume":"26","author":"Potteaux","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"2019111809433455900_B24","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1096\/fj.07-8076com","article-title":"Bone marrow progenitor cells contribute to repair and remodeling of the lung and heart in a rat model of progressive pulmonary hypertension.","volume":"22","author":"Spees","year":"2008","journal-title":"FASEB J"},{"issue":"3","key":"2019111809433455900_B25","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1084\/jem.20050195","article-title":"Organic cation transporter 3 modulates murine basophil functions by controlling intracellular histamine levels.","volume":"202","author":"Schneider","year":"2005","journal-title":"J Exp Med"},{"issue":"6","key":"2019111809433455900_B26","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1183\/09031936.00045710","article-title":"Targeting of c-kit+ haematopoietic progenitor cells prevents hypoxic pulmonary hypertension.","volume":"37","author":"Gambaryan","year":"2011","journal-title":"Eur Respir J"},{"issue":"1","key":"2019111809433455900_B27","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1164\/rccm.201006-0905OC","article-title":"C-kit-positive cells accumulate in remodeled vessels of idiopathic pulmonary arterial hypertension.","volume":"184","author":"Montani","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"32","key":"2019111809433455900_B28","doi-asserted-by":"crossref","first-page":"13141","DOI":"10.1073\/pnas.1103964108","article-title":"Ineffective erythropoiesis with reduced red blood cell survival in serotonin-deficient mice.","volume":"108","author":"Amireault","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"2019111809433455900_B29","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1182\/blood-2008-12-164004","article-title":"The granulocyte-macrophage colony-stimulating factor receptor: linking its structure to cell signaling and its role in disease.","volume":"114","author":"Hercus","year":"2009","journal-title":"Blood"},{"issue":"9","key":"2019111809433455900_B30","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1164\/rccm.201001-0123OC","article-title":"Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapy.","volume":"182","author":"Ghofrani","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"2019111809433455900_B31","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1161\/01.ATV.0000206123.94140.f3","article-title":"Role of circulating vascular progenitors in angiogenesis, vascular healing, and pulmonary hypertension: lessons from animal models.","volume":"26","author":"Sata","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"2019111809433455900_B32","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1096\/fj.07-8636com","article-title":"Activation of c-kit is necessary for mobilization of reparative bone marrow progenitor cells in response to cardiac injury.","volume":"22","author":"Fazel","year":"2008","journal-title":"FASEB J"},{"issue":"5","key":"2019111809433455900_B33","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1183\/09031936.00052210","article-title":"Imatinib inhibits bone marrow-derived c-kit+ cell mobilisation in hypoxic pulmonary hypertension.","volume":"36","author":"Gambaryan","year":"2010","journal-title":"Eur Respir J"},{"issue":"1","key":"2019111809433455900_B34","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0022-3565(24)38879-2","article-title":"Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors.","volume":"295","author":"Buchdunger","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"2019111809433455900_B35","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1124\/mol.109.058057","article-title":"Parallel functional activity profiling reveals valvulopathogens are potent 5-HT2B receptor agonists: implications for drug safety assessment.","volume":"76","author":"Huang","year":"2009","journal-title":"Mol Pharmacol"},{"issue":"10","key":"2019111809433455900_B36","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1172\/JCI24838","article-title":"Reversal of experimental pulmonary hypertension by PDGF inhibition.","volume":"115","author":"Schermuly","year":"2005","journal-title":"J Clin Invest"},{"issue":"3","key":"2019111809433455900_B37","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0002-9343(99)80156-9","article-title":"Increased plasma serotonin in primary pulmonary hypertension.","volume":"99","author":"Herv\u00e9","year":"1995","journal-title":"Am J Med"},{"issue":"1","key":"2019111809433455900_B38","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.HYP.0000252210.58849.78","article-title":"Effect of tryptophan hydroxylase 1 deficiency on the development of hypoxia-induced pulmonary hypertension.","volume":"49","author":"Morecroft","year":"2007","journal-title":"Hypertension"},{"issue":"7","key":"2019111809433455900_B39","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1634\/stemcells.2005-0290","article-title":"Despite inhibition of hematopoietic progenitor cell growth in vitro, the tyrosine kinase inhibitor imatinib does not impair engraftment of human CD133+ cells into NOD\/SCIDbeta2mNull mice.","volume":"24","author":"Pirson","year":"2006","journal-title":"Stem Cells"},{"issue":"1","key":"2019111809433455900_B40","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/10245330500322370","article-title":"The effect of 5-hydroxtryptamine on the regulation of megakaryocytopoiesis.","volume":"11","author":"Liu","year":"2006","journal-title":"Hematology"},{"issue":"11","key":"2019111809433455900_B41","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1182\/blood.V95.11.3451","article-title":"Nitric oxide induces apoptosis in megakaryocytic cell lines.","volume":"95","author":"Battinelli","year":"2000","journal-title":"Blood"},{"issue":"10","key":"2019111809433455900_B42","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1096\/fj.02-1122fje","article-title":"Serotonin is a novel survival factor of cardiomyocytes: mitochondria as a target of 5-HT2B-receptor signaling.","volume":"17","author":"Nebigil","year":"2003","journal-title":"FASEB J"},{"issue":"9","key":"2019111809433455900_B43","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1182\/blood-2005-08-3319","article-title":"High levels of circulating CD34 cells, dacrocytes, clonal hematopoiesis, and JAK2 mutation differentiate myelofibrosis with myeloid metaplasia from secondary myelofibrosis associated with pulmonary hypertension.","volume":"107","author":"Popat","year":"2006","journal-title":"Blood"},{"issue":"5302","key":"2019111809433455900_B44","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1126\/science.275.5302.964","article-title":"Isolation of putative progenitor endothelial cells for angiogenesis.","volume":"275","author":"Asahara","year":"1997","journal-title":"Science"},{"issue":"6","key":"2019111809433455900_B45","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/89121","article-title":"Host BM cells are a source of donor intimal smooth- muscle-like cells in murine aortic transplant arteriopathy.","volume":"7","author":"Shimizu","year":"2001","journal-title":"Nat Med"},{"issue":"4","key":"2019111809433455900_B46","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nm0402-403","article-title":"Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis.","volume":"8","author":"Sata","year":"2002","journal-title":"Nat Med"},{"issue":"35","key":"2019111809433455900_B47","doi-asserted-by":"crossref","first-page":"13156","DOI":"10.1073\/pnas.0604203103","article-title":"Myeloid lineage progenitors give rise to vascular endothelium.","volume":"103","author":"Bailey","year":"2006","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/7\/1772\/1356818\/zh800712001772.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/7\/1772\/1356818\/zh800712001772.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,16]],"date-time":"2025-03-16T06:54:35Z","timestamp":1742108075000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/119\/7\/1772\/30151\/Serotonin-5HT2B-receptors-are-required-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,16]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,2,16]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-06-358374","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,16]]}}}